Anthera Pharmaceuticals Inc — Form D/A
Anthera Pharmaceuticals Inc of HAYWARD, CA, a company, filed a Form D amendment with the SEC on 2018-01-11. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-01-11
- Form: D/A
- Accession: 0001316175-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $15.0M
- Investors: 21
- Date of first sale: 2017-10-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-298435
Issuer
- Name: Anthera Pharmaceuticals Inc
- CIK: 0001316175
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 25801 INDUSTRIAL BOULEVARD, SUITE B, HAYWARD, CA, 94545
- Phone: (510) 856-5600
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| May Liu | Executive Officer | Hayward, CA |
Other filings by this issuer (1)
More